Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-28 Hall Ashley Chief Development Officer Option exercise +15,625 $1.80 $28K 55,225
2023-08-28 Hall Ashley Chief Development Officer Sale −15,625 $6.28 $98K 39,600
2023-08-28 Hall Ashley Chief Development Officer Option exercise · Stock option (right to buy) −15,625 109,375
2023-07-26 GREY MICHAEL G Executive Chairman Gift −50,000 0
2023-06-23 Novo Holdings A/S 10% owner Sale −100,000 $7.10 $710K 3,330,337
2023-06-06 Mathers Edward T Director Grant or award · Stock Option (right to buy) −17,500 17,500
2023-06-06 Blunt Roshawn A. Director Grant or award · Stock Option (right to buy) +14,815 14,815
2023-06-06 GREY MICHAEL G Executive Chairman Grant or award · Stock Option (right to buy) +17,500 17,500
2023-06-06 Hoelscher Paul W. Director Grant or award · Stock Option (right to buy) +17,500 17,500
2023-06-06 Muralidhar Bali Director Grant or award · Stock Option (right to buy) +17,500 17,500
2023-06-06 O'Donnell Niall Director Grant or award · Stock Option (right to buy) +17,500 17,500
2023-06-06 Seltzer Stacey Denenberg Director Grant or award · Stock Option (right to buy) +17,500 17,500
2023-06-06 Dube Eric M Director Grant or award · Stock Option (right to buy) +17,500 17,500
2023-05-08 O'Donnell Niall Director Purchase +125,000 $8.00 $1.0M 2,188,713
2022-12-09 Lam Jennifer VP of Finance & Administration Grant or award · Stock option (right to buy) +90,000 90,000
2022-12-09 Hall Ashley Chief Development Officer Grant or award · Stock option (right to buy) +125,000 125,000
2022-12-09 FLESHER GREGORY J. President and CEO Grant or award · Stock option (right to buy) +300,000 300,000
2022-12-09 Dorenbaum Alejandro Chief Medical Officer Grant or award · Stock option (right to buy) +125,000 125,000
2022-12-09 Cruse Michael Chief Operating Officer Grant or award · Stock option (right to buy) +125,000 125,000
2022-09-01 Cruse Michael Chief Operating Officer Purchase +7,500 $3.39 $25K 13,697

Page 7 of 8 · 154 trades